Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 23


What Do We Know about the Role of miRNAs in Pediatric Sarcoma?

Kelly LC, Lázaro A, O'Sullivan MJ.

Int J Mol Sci. 2015 Jul 22;16(7):16593-621. doi: 10.3390/ijms160716593. Review.


Adamantinoma-like Ewing family tumors of the head and neck: a pitfall in the differential diagnosis of basaloid and myoepithelial carcinomas.

Bishop JA, Alaggio R, Zhang L, Seethala RR, Antonescu CR.

Am J Surg Pathol. 2015 Sep;39(9):1267-74. doi: 10.1097/PAS.0000000000000460.


The cell cycle regulator CCDC6 is a key target of RNA-binding protein EWS.

Duggimpudi S, Larsson E, Nabhani S, Borkhardt A, Hoell JI.

PLoS One. 2015 Mar 9;10(3):e0119066. doi: 10.1371/journal.pone.0119066. eCollection 2015.


New strategies in ewing sarcoma: lost in translation?

Arnaldez FI, Helman LJ.

Clin Cancer Res. 2014 Jun 15;20(12):3050-6. doi: 10.1158/1078-0432.CCR-13-0633. Epub 2014 Apr 22.


Characterization and drug resistance patterns of Ewing's sarcoma family tumor cell lines.

May WA, Grigoryan RS, Keshelava N, Cabral DJ, Christensen LL, Jenabi J, Ji L, Triche TJ, Lawlor ER, Reynolds CP.

PLoS One. 2013 Dec 2;8(12):e80060. doi: 10.1371/journal.pone.0080060. eCollection 2013.


Adult ewing sarcoma: survival and local control outcomes in 102 patients with localized disease.

Ahmed SK, Robinson SI, Okuno SH, Rose PS, Laack NN.

Sarcoma. 2013;2013:681425. doi: 10.1155/2013/681425. Epub 2013 Jun 11.


A Decade in Banking Ewing Sarcoma: A Report from the Children's Oncology Group.

Borinstein SC, Beeler N, Block JJ, Gorlick R, Grohar P, Jedlicka P, Krailo M, Morris C, Phillips S, Siegal GP, Lawlor ER, Lessnick SL; COG Ewing Sarcoma Biology Committee.

Front Oncol. 2013 Mar 20;3:57. doi: 10.3389/fonc.2013.00057. eCollection 2013.


Ewing sarcoma of the bone in children under 6 years of age.

De Ioris MA, Prete A, Cozza R, Podda M, Manzitti C, Pession A, Schiavello E, Contoli B, Balter R, Fagioli F, Bisogno G, Amoroso L, Locatelli F, Luksch R.

PLoS One. 2013;8(1):e53223. doi: 10.1371/journal.pone.0053223. Epub 2013 Jan 31.


The biology of ewing sarcoma.

Ross KA, Smyth NA, Murawski CD, Kennedy JG.

ISRN Oncol. 2013;2013:759725. doi: 10.1155/2013/759725. Epub 2013 Jan 10.


Children's Oncology Group's 2013 blueprint for research: bone tumors.

Gorlick R, Janeway K, Lessnick S, Randall RL, Marina N; COG Bone Tumor Committee.

Pediatr Blood Cancer. 2013 Jun;60(6):1009-15. doi: 10.1002/pbc.24429. Epub 2012 Dec 19. Review.


Nonmetastatic Ewing's Sarcoma of the Lumbar Spine in an Adult Patient.

Iacoangeli M, Dobran M, Di Rienzo A, di Somma LG, Alvaro L, Moriconi E, Nocchi N, Gladi M, Scerrati M.

Case Rep Oncol Med. 2012;2012:165289. doi: 10.1155/2012/165289. Epub 2012 Oct 24.


EWS/FLI1 regulates EYA3 in Ewing sarcoma via modulation of miRNA-708, resulting in increased cell survival and chemoresistance.

Robin TP, Smith A, McKinsey E, Reaves L, Jedlicka P, Ford HL.

Mol Cancer Res. 2012 Aug;10(8):1098-108. doi: 10.1158/1541-7786.MCR-12-0086. Epub 2012 Jun 20.


Molecular pathogenesis and targeted therapeutics in Ewing sarcoma/primitive neuroectodermal tumours.

Kelleher FC, Thomas DM.

Clin Sarcoma Res. 2012 Feb 1;2(1):6. doi: 10.1186/2045-3329-2-6.


Should Aggressive Surgical Local Control Be Attempted in All Patients with Metastatic or Pelvic Ewing's Sarcoma?

Thorpe SW, Weiss KR, Goodman MA, Heyl AE, McGough RL.

Sarcoma. 2012;2012:953602. doi: 10.1155/2012/953602. Epub 2012 Mar 4.


Current therapeutic approaches in metastatic and recurrent ewing sarcoma.

Huang M, Lucas K.

Sarcoma. 2011;2011:863210. doi: 10.1155/2011/863210. Epub 2010 Dec 1.


Pathobiologic markers of the ewing sarcoma family of tumors: state of the art and prediction of behaviour.

Pinto A, Dickman P, Parham D.

Sarcoma. 2011;2011:856190. doi: 10.1155/2011/856190. Epub 2010 Oct 14.


Current treatment protocols have eliminated the prognostic advantage of type 1 fusions in Ewing sarcoma: a report from the Children's Oncology Group.

van Doorninck JA, Ji L, Schaub B, Shimada H, Wing MR, Krailo MD, Lessnick SL, Marina N, Triche TJ, Sposto R, Womer RB, Lawlor ER.

J Clin Oncol. 2010 Apr 20;28(12):1989-94. doi: 10.1200/JCO.2009.24.5845. Epub 2010 Mar 22.


VEGF165 promotes the osteolytic bone destruction of ewing's sarcoma tumors by upregulating RANKL.

Guan H, Zhou Z, Cao Y, Duan X, Kleinerman ES.

Oncol Res. 2009;18(2-3):117-25.


Caveolin-1 promotes resistance to chemotherapy-induced apoptosis in Ewing's sarcoma cells by modulating PKCalpha phosphorylation.

Tirado OM, MacCarthy CM, Fatima N, Villar J, Mateo-Lozano S, Notario V.

Int J Cancer. 2010 Jan 15;126(2):426-36. doi: 10.1002/ijc.24754.


Very late local recurrence of Ewing's sarcoma--can you ever say 'cured'? A report of two cases and literature review.

Hanna SA, David LA, Gikas PD, Tindall AJ, Cannon SR, Briggs TW.

Ann R Coll Surg Engl. 2008 Oct;90(7):W12-5. doi: 10.1308/147870808X303146. Review.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk